Reproductive BioMedicine Online
Volume 19, Issue 5 , Pages 695-699, November 2009

Improved monitoring of ovarian stimulation using 3D transvaginal ultrasound plus automated volume count

  • Maximilian Murtinger

      Affiliations

    • IVF Centers Prof. Zech, Bregenz, Austria
    • MM and AA contributed equally to this paper
  • ,
  • Alexander Aburumieh

      Affiliations

    • IVF Centers Prof. Zech, Bregenz, Austria
    • MM and AA contributed equally to this paper
  • ,
  • Paul Rubner

      Affiliations

    • IVF Centers Prof. Zech, Bregenz, Austria
  • ,
  • Verena Eichel

      Affiliations

    • IVF Centers Prof. Zech, Bregenz, Austria
  • ,
  • Mathias H Zech

      Affiliations

    • IVF Centers Prof. Zech, Bregenz, Austria
  • ,
  • Nicolas H Zech

      Affiliations

    • IVF Centers Prof. Zech, Bregenz, Austria
    • Departments for Obstetrics and Gynecology, Unit of Gynecological Endocrinology and Reproductive Medicine, University of Graz, Austria
    • Corresponding Author InformationCorrespondence:

Received 5 February 2009; received in revised form 19 February 2009; accepted 22 July 2009. published online 02 August 2010.

Declaration: The authors report no financial or commercial conflicts of interest.

Abstract 

Two-dimensional transvaginal ultrasound (2D) is typically performed to monitor follicle growth in IVF and to determine the optimal time for administering human chorionic gonadotrophin. However, 2D only provides an approximation of the real volume of follicles and therefore cannot be used to guarantee standards for follicular measurement. The automated measurement of follicular size in three dimensions (3D) using a software programme that identifies and quantifies hypoechoic regions within a 3D dataset might provide an objective, fast, valid and reliable standard for such measurements. A prospective controlled study (group I: 20 patients, 2D; group II: 20 patients, 3D) investigated how the criteria for triggering oocyte maturation that are normally used in 2D compare to the new and more accurate method of measuring follicles using 3D-based automated volume count. Significantly more oocytes were fertilized (group 1: 7.1±4.5, group 2: 11.5±6.4; P<0.03) when using 3D technology and automated volume count. The study assumes that the automated volume count more closely mirrors the biological reality, which means that it can also be used to guarantee the quality standards established by the European Union directive on tissues and cells (2004/23/EC). This new technology therefore holds great promise of becoming the new standard for monitoring follicular growth in IVF.

Keywords: automated volume count, in-vitro fertilization, monitoring, ovarian stimulation, three-dimensional ultrasound

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Maximilian Murtinger received his MD at the University of Vienna in 1986. After specialization as a trauma surgeon in 2003, he changed to the field of reproductive medicine and endocrinology and is currently finishing his specialization in obstetrics and gynecology. His current interest is in ultrasound techniques, especially related to follicular measurements in stimulated cycles and in establishing clinical standards related to the quality criteria set by the European Union directive on tissues and cells (2004/23/EC). In addition, Dr Murtinger is developing requirements for software used in obstetrics and gynecology, especially for reproductive medicine and endocrinology.Dr Maximilian Murtinger

PII: S1472-6483(09)00072-8

doi:10.1016/j.rbmo.2009.09.008

Reproductive BioMedicine Online
Volume 19, Issue 5 , Pages 695-699, November 2009